Global Insulin Delivery Devices Market to Witness 7% CAGR During 2015 - 2020: P&S Market Research
NEW YORK, August 25, 2015 /PRNewswire/ --
The global insulin delivery devices market was valued at $9,499.1 million in 2014, and it is expected to grow at a CAGR of 7% during 2015-2020. The global insulin delivery devices market is increasing due to increase in geriatric population and rise in global obesity population. The increase in prevalence of diabetes is one of the leading causes of death and has increased risk of developing number of serious health problems. According to International Diabetes Federation in 2013, approximately 382 million people were suffering from diabetes and approximately 592 million people are expected to suffer by 2035. Similarly, technological advancement is insulin delivery devices are leading to increased acceptances of such devices. Insulin pens and pumps have various advantages, which help in delivering accurate dosage of insulin and maintain the normal level of insulin in the body.
(Logo: http://photos.prnewswire.com/prnh/20150727/756778)
Browse report description with TOC on "Global Industry Insight: Insulin Delivery Devices Market Development and Demand Forecast to 2020" at: https://www.psmarketresearch.com/market-analysis/insulin-delivery-devices
Based on type, insulin syringe has the largest market share in the insulin delivery devices market globally, as it is a convenient mode of insulin delivery. However, insulin pump is the fastest growing segment in the insulin delivery device market and it is expected to grow at a CAGR of 7.6% during the forecast period due to technological advancements in insulin pumps to maintain the level of insulin in the body for diabetic patients.
The information and data in the publication "Global Industry Insight: Insulin Delivery Devices Market Development and Demand Forecast to 2020" represent the research and analysis of data from various primary and secondary sources. The top-down approach has been used to calculate the global insulin delivery device market by type. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, aided by informed and detailed online and offline research.
Various initiates, such as programs, activities and campaigns, are implemented by IDF, NGOs, diabetes associations and health departments to create awareness among people regarding effects of diabetes and correct method of treatment. The increasing awareness of diabetes and increasing prevalence of diabetes is driving the demand for insulin delivery devices. The increasing role of home infusion therapy provides a vital role in the treatment of diabetes with the help of infusion insulin pumps. Infusion insulin pumps provide an accurate dosage of insulin to diabetic patient throughout the day. This is significantly increasing the demand for insulin delivery devices in the market. In addition, artificial pancreas is also gaining popularity in the insulin delivery devices market globally.
Browse related reports at:
https://www.psmarketresearch.com/industry-report/medical-devices
However, certain restraints such as hazards and risks associated with drug delivery devices and high insulin analogue cost are hindering the market growth. Technological advancement in insulin delivery devices is expected to create demand for insulin delivery devices market during the forecast period. The increasing awareness about diabetes and improving healthcare facilities in developing countries, such as China, India, and Brazil, are laying significant opportunities for insulin delivery devices market. Asia insulin delivery devices market is expected to witness the fastest growth of CAGR 8.0% globally during the period 2015 - 2020.
The key companies operating in the global insulin delivery devices market are Medtronic, Inc., F. Hoffmann-La Roche, Ltd., Abbott Laboratories Inc. Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Becton Dickinson and Company, Insulet Corporation, B. Braun Melsungen AG, Animas Corporation, and Ypsomed Holdings AG.
Browse other reports:
Global Electronic Medical Record Systems (EMR) Market: https://www.psmarketresearch.com/market-analysis/electronic-medical-records-market
Global Microfluidic Devices Market: https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market
Global Biosensors Market: https://www.psmarketresearch.com/market-analysis/biosensors-market
Global Drug of Abuse Testing Market: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing
INSULIN DELIVERY DEVICES MARKET SEGMENTATION
Market breakdown by type
- Insulin Syringe
- Insulin Pumps
- Insulin Pens
- Insulin Jet Injectors
- Others
Market breakdown by geography
North America
- The U.S.
- Canada
Europe
- France
- Germany
- Italy
- Spain
- The U.K.
Asia
- China
- India
- Japan
Rest of the World (RoW)
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Ms Somya
Manager - Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Share this article